Cotecna, a leading provider of Testing, Inspection and Certification (TIC) services, has acquired Energon Labs, a cGMP-compliant, USFDA-inspected analytical testing laboratory based in Hyderabad, India. The acquisition, announced on October 19, 2026, strengthens Cotecna's global Life Sciences platform and expands its pharmaceutical testing capabilities across the Pharmaceutical, Biopharmaceutical, Medical Device and Packaging sectors. The move is significant for the global healthcare supply chain because India is one of the world's fastest-growing pharmaceutical markets and a critical manufacturing hub, and the deal enhances Cotecna's ability to support both Indian and international customers with high-quality, regulatory-compliant testing services.
Energon Labs is certified to ISO 9001:2015 and ISO 17025:2017 and serves customers across India, the United States, Asia-Pacific, and the Middle East. Its location in Hyderabad, one of the world's leading pharmaceutical and biotechnology hubs, provides Cotecna with access to highly specialized scientific talent, advanced laboratory infrastructure and a well-established pharmaceutical ecosystem. The acquisition also complements Cotecna's growing pharmaceutical testing network, which includes Cotecna Life Sciences, Shiva Analyticals and Neotron Pharma, strengthening the Group's ability to support customers throughout the product lifecycle and address evolving global quality, compliance and regulatory requirements.
Energon offers a comprehensive portfolio of analytical testing and quality assurance services, including analytical method development and validation, stability studies, impurity profiling, extractables and leachables, glass delamination studies, peptides and oligonucleotide characterisation, raw material and finished product testing, in-vitro binding studies, packaging compatibility studies, and regulatory support services. These capabilities will further strengthen Cotecna's position as a trusted partner to pharmaceutical manufacturers serving regulated markets worldwide.
Sebastien Dannaud, Chief Executive Officer of Cotecna Group, commented: “We are pleased to welcome Energon Labs to the Cotecna Group. This acquisition represents another important step to support our ambition to become one of the largest providers of Life Sciences testing services in India, and strengthens our position in one of the world's most important pharmaceutical markets.” Amit Chopra, CEO South Asia and Middle East, Cotecna Group, added that the acquisition aligns with the strategy of building a comprehensive pharmaceutical testing ecosystem across key growth markets, and that Energon's technical capabilities, experienced team and established customer relationships will enhance the ability to serve pharmaceutical, biopharmaceutical and medical device companies across India and globally.
Manikanth Reddy, Founder of Energon, said: "Joining the Cotecna Group opens an exciting new chapter for Energon Labs. Over the years, we have focused on building a laboratory recognized for quality, scientific expertise and reliability. Becoming part of a global organization like Cotecna provides new opportunities to expand our capabilities, strengthen our service offerings and deliver even greater value to our customers." The deal is expected to deliver greater responsiveness, scalability and operational efficiency across key markets, and it underscores the growing importance of independent, regulatory-compliant testing capacity as global pharmaceutical supply chains diversify. The original release is available on www.newmediawire.com.
